IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 323
EU - Europa 210
AS - Asia 134
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 322
IT - Italia 112
HK - Hong Kong 61
DE - Germania 38
SG - Singapore 32
UA - Ucraina 22
CN - Cina 17
KR - Corea 15
FI - Finlandia 12
CZ - Repubblica Ceca 10
FR - Francia 7
IL - Israele 4
SE - Svezia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
GB - Regno Unito 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
IN - India 1
LU - Lussemburgo 1
ZA - Sudafrica 1
Totale 673
Salva come PNG Salva come JPEG
Città #
Chandler 78
Hong Kong 58
Boardman 28
Munich 25
West Jordan 18
Cagliari 16
Seoul 15
Singapore 15
Princeton 14
Sassari 14
Alghero 12
Jacksonville 12
New York 12
Dallas 10
Helsinki 10
Ashburn 7
Brno 7
Wilmington 7
Ann Arbor 6
Dearborn 6
Nanjing 6
Seattle 6
Selargius 6
Beijing 5
Milan 5
Bologna 3
Nuremberg 3
Olomouc 3
Salerno 3
Torino 3
Agrigento 2
Brussels 2
Città Di Castello 2
Istanbul 2
Jerusalem 2
Lappeenranta 2
Melbourne 2
Nanchang 2
Oakland 2
Rio de Janeiro 2
Tel Aviv 2
Abidjan 1
Burgas 1
Como 1
Dalmine 1
Dubai 1
Gauteng 1
Hangzhou 1
Hebei 1
Legnano 1
Luxembourg 1
Ningbo 1
Ottawa 1
Padova 1
Pune 1
Roubaix 1
Santena 1
Stockholm 1
Washington 1
Woodbridge 1
Totale 454
Salva come PNG Salva come JPEG
Nome #
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 61
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 53
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 53
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 41
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 32
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 30
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 29
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 28
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 23
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 21
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 20
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 19
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 18
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 18
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 18
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 18
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 17
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 17
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 16
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 15
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 14
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 12
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 12
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 12
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 12
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 12
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 12
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 10
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 10
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 10
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 10
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 9
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 8
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 8
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 7
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 7
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 5
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 5
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 4
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 4
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 3
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 2
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 2
Totale 737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 1 0 5 4 5 7 2 4 8 4 2
2020/202142 4 0 4 5 13 0 5 0 5 6 0 0
2021/202243 5 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/202569 44 25 0 0 0 0 0 0 0 0 0 0
Totale 737